Filings under NXL by New Plan Excel Realty Trust Inc (CIK 0000798288) from Mar 1, 2006 to Apr 20, 2007 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 19, 2025 | Kazden Alan | Director | Grant(A) | 100K | — | $0 |
| Dec 19, 2025 | Hu Ben | Director | Grant(A) | 100K | — | $0 |
| Dec 19, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality - Regulatory | Grant(A) | 100K | — | $0 |
| Dec 19, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 1.0M | — | $0 |
| Dec 19, 2025 | Van Fleet Justin | CFO | Grant(A) | 100K | — | $0 |
| Dec 19, 2025 | White Mark | CEO, Director | Grant(A) | 1.0M | — | $0 |
| Sep 29, 2025 | Kazden Alan | Director | Grant(A) | 36K | — | $0 |
| Sep 29, 2025 | Hu Ben | Director | Grant(A) | 36K | — | $0 |
| Sep 29, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 36K | — | $0 |
| Sep 29, 2025 | Osser Leonard | 10% Owner | Grant(A) | 83K | — | $0 |
| Sep 12, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 100K | — | $0 |
| Sep 12, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 203K | — | $0 |
| Sep 12, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality - Regulatory | Grant(A) | 20K | — | $0 |
| Sep 10, 2025 | Osser Leonard | 10% Owner | Sell(S) | 23K | $0.02 | $463 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 150K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Mar 12, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | Buy(P) | 6K | $2.20 | $13K |
| Feb 26, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 140K | — | $0 |
| Feb 26, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 125K | — | $0 |
| Feb 26, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 654K | — | $0 |
| Feb 26, 2025 | White Mark | President and CEO, Director | Grant(A) | 940K | — | $0 |
| Feb 26, 2025 | White Mark | President and CEO, Director | Grant(A) | 447K | — | $0 |
| Feb 4, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $2.98 | $3K |
| Feb 4, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $3.10 | $3K |
| Jan 28, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 2K | $2.70 | $4K |
| Jan 23, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $2.70 | $3K |
| Jan 13, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 2K | $2.50 | $5K |
| Oct 28, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 500 | $2.19 | $1K |
| Sep 30, 2024 | Hu Ben | Director | Grant(A) | 175K | — | $0 |
| Sep 30, 2024 | Bernhard Leslie | Director | Grant(A) | 50K | — | $0 |
| Sep 30, 2024 | Elson Marilyn | 10% Owner | Grant(A) | 700K | — | $0 |
| Sep 23, 2024 | Osser Leonard | Insider | Grant(A) | 700K | — | $0 |
| Aug 13, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $0.95 | $950 |
| Jun 28, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $1.75 | $2K |
| Jun 18, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 2K | $0.71 | $1K |
| Jun 10, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 2K | $0.65 | $1K |
| Jun 10, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $0.62 | $620 |
| Sep 28, 2022 | Osser Leonard | Insider | Buy(P) | 10K | $0.40 | $4K |
| Sep 28, 2022 | Osser Leonard | Insider | Buy(P) | 10K | $1.12 | $11K |
| Sep 16, 2022 | Kazden Alan | Director | Buy(P) | 3K | $0.40 | $1K |
| Sep 16, 2022 | Owens David | Chief Medical Officer, Director | Buy(P) | 3K | $0.40 | $1K |
| Sep 16, 2022 | White Mark | President/CEO, Director | Buy(P) | 25K | $0.40 | $10K |
| Sep 16, 2022 | Kazden Alan | Director | Buy(P) | 3K | $4.15 | $10K |
| Sep 16, 2022 | Morad Rick | Director | Buy(P) | 3K | $4.15 | $10K |
| Sep 16, 2022 | Owens David | Chief Medical Officer, Director | Buy(P) | 3K | $4.15 | $10K |
| Sep 16, 2022 | Osser Leonard | Insider | Buy(P) | 36K | $4.15 | $149K |
| Sep 16, 2022 | Osser Leonard | Insider | Buy(P) | 100K | $0.40 | $40K |
| Sep 15, 2022 | White Mark | President/CEO, Director | Buy(P) | 25K | $4.15 | $104K |
| Sep 15, 2022 | White Mark | President/CEO, Director | Buy(P) | 25K | $4.15 | $104K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Nexalin Technology, Inc., SEC CIK 0001527352. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under NXL and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for NXL